Tobramycin
d-Streptamine, O-3-amino-3-deoxy- ![]() ![]() O-3-Amino-3-deoxy- ![]() ![]() ![]() ![]() ![]() » Tobramycin has a potency of not less than 900 µg of C18H37N5O9 per mg, calculated on the anhydrous basis.
Packaging and storage—
Preserve in tight containers.
Labeling—
Where it is intended for use in preparing injectable or ophthalmic dosage forms, the label states that it is sterile or must be subjected to further processing during the preparation of injectable or ophthalmic dosage forms.
Identification—
A:
Prepare a solution of it in water containing 6 mg per mL. Apply 3 µL of this test solution, 3 µL of a Standard solution of USP Tobramycin RS containing 6 mg per mL, and 3 µL of a mixture of equal volumes of the two solutions to a suitable thin-layer chromatographic plate (see Chromatography
![]() ![]() ![]()
pH
![]() ![]()
Water, Method I
![]() ![]()
Residue on ignition
![]() ![]()
Heavy metals, Method II
![]() ![]()
Chromatographic purity—
Diluted sodium hypochlorite solution—
Dilute 20 mL of sodium hypochlorite solution with water to obtain 100 mL of solution.
Starch-potassium iodide reagent—
Dissolve 1.1 g of potassium iodide in 60 mL of water, boil for 15 minutes, and slowly add a suspension of 1.5 g of soluble starch in 10 mL of water. Add 25 mL of water, and boil for 10 minutes. Allow to cool, dilute with water to 100 mL, and mix.
Procedure—
Transfer 50 mg of Tobramycin to a 10-mL volumetric flask, add 7 mL of water to dissolve it, and adjust with 1 N sulfuric acid to a pH of 5.5 ± 0.4. Dilute with water to volume, and mix to obtain the test solution. Prepare a standard solution by diluting the test solution quantitatively with water to obtain a solution containing 0.05 mg per mL. Separately apply 1 µL of these solutions to a thin-layer chromatographic plate (see Chromatography
![]() ![]() ![]()
Other requirements—
Where the label states that Tobramycin is sterile, it meets the requirements for Sterility and Bacterial endotoxins under Tobramycin for Injection. Where the label states that Tobramycin must be subjected to further processing during the preparation of injectable dosage forms, it meets the requirements for Bacterial endotoxins under Tobramycin for Injection. Where it is intended for use in preparing ophthalmic dosage forms, it is exempt from the requirements for Bacterial endotoxins.
Assay—
Mobile phase—
Dissolve 2.0 g of tris(hydroxymethyl)aminomethane in about 800 mL of water. To this solution add 20 mL of 1 N sulfuric acid, dilute with acetonitrile to obtain 2000 mL of solution, and mix. Allow to cool, and pass through a filter of 0.2-µm or finer porosity. Make adjustments if necessary (see System Suitability under Chromatography
![]() ![]()
2
,4-Dinitrofluorobenzene reagent—Prepare a solution of 2,4-dinitrofluorobenzene in alcohol containing 10 mg per mL. This solution may be used for 5 days if refrigerated when not in use.
Tris
(hydroxymethyl)aminomethane reagent—Prepare a stock solution of tris(hydroxymethyl)aminomethane in water containing 15 mg per mL. This stock solution may be used for 1 month if refrigerated when not in use. Transfer 40 mL of this stock solution to a 200-mL volumetric flask, add dimethyl sulfoxide with mixing, dilute with dimethyl sulfoxide to volume, and mix. Use this reagent within 4 hours. [note—If kept immersed in an ice-water bath below 10
![]()
Standard preparation—
Transfer about 55 mg of USP Tobramycin RS, accurately weighed, to a 50-mL volumetric flask, add 1 mL of 1 N sulfuric acid and enough water to dissolve it, dilute with water to volume, and mix. Transfer 10.0 mL of this solution to a second 50-mL volumetric flask, dilute with water to volume, and mix. This solution contains about 0.22 mg of USP Tobramycin RS per mL.
Assay preparation—
Transfer about 55 mg of Tobramycin, accurately weighed, to a 50-mL volumetric flask, add 1 mL of 1 N sulfuric acid and enough water to dissolve it, dilute with water to volume, and mix. Transfer 10.0 mL of this solution to a second 50-mL volumetric flask, dilute with water to volume, and mix.
Derivatization procedure—
[note—Heat all solutions at the same temperature and for the same duration of time as indicated. Move all flasks to and from the 60
![]() ![]()
Resolution solution—
Prepare a fresh solution of p-naphtholbenzein in acetonitrile containing about 0.24 mg per mL. Transfer 2 mL of this solution to a 10-mL volumetric flask, dilute with Derivatized standard preparation to volume, and use promptly.
Chromatographic system
(see Chromatography
![]() ![]()
Procedure—
Separately inject equal volumes (about 20 µL) of the Derivatized standard preparation and the Derivatized assay preparation into the chromatograph, record the chromatograms, and measure the area responses for the major peaks. Calculate the quantity, in µg, of C18H37N5O9 in each mg of the Tobramycin taken by the formula:
250(CE / W)(rU / rS)
in which C is the concentration, in mg per mL, of USP Tobramycin RS in the Standard preparation; E is the tobramycin equivalent, in µg per mg, of USP Tobramycin RS; W is the weight, in mg, of the portion of Tobramycin taken; and rU and rS are the tobramycin peak area responses obtained from the Derivatized assay preparation and the Derivatized standard preparation, respectively.
Auxiliary Information—
Please check for your question in the FAQs before contacting USP.
Chromatographic Column—
USP32–NF27 Page 3756
Chromatographic columns text is not derived from, and not part of, USP 32 or NF 27.
|